FOREX-Aussie jumps higher on China virus drug reports; dollar firm

Published 05/02/2020, 11:42
Updated 05/02/2020, 11:45
© Reuters.  FOREX-Aussie jumps higher on China virus drug reports; dollar firm
LCO
-

* Graphic: World FX rates in 2019 http://tmsnrt.rs/2egbfVh

By Saikat Chatterjee

LONDON, Feb 5 (Reuters) - The Australian dollar hopped half

a percent higher on Wednesday and the Norwegian crown advanced,

as reports of medical breakthroughs in the fight against the new

coronavirus boosted growth-linked currencies.

Media reported that a Chinese university had found a drug to

treat people with the virus, while researchers in Britain had

made a "significant breakthrough" in finding a vaccine.

While the Chinese report was a day old and the British

report indicated the research trials were in early stages,

traders used the headlines to load up on risky assets.

"The fact that the risk assets are so supported today may

indicate that investors are hungry for risk," said Valentin

Marinov, the London-based head of G10 FX Strategy at Credit

Agricole.

Against the greenback, the Aussie rose 0.5% at $0.6770 with

some hawkish comments from the central bank governor in Asian

trading also boosting sentiment. The Australian currency is

considered as a barometer of risk appetite towards China given

its close economic ties with Beijing.

Appetite for risk also spread to other currencies including

the Norwegian crown NOK=D3 and its Swedish counterpart

SEK=D3 with both currencies rising 0.3% against the dollar.

A climb in Brent oil prices LCOc1 above the $55 per barrel

line also supported gains.

Gains for riskier currencies translated into weakness for

currencies perceived as safe-havens such as the Japanese yen

JPY=EBS and the Swiss franc CHF=EBS with both of them

weakening against the dollar.

China's Changjiang Daily, the official newspaper of the city

of Wuhan where the virus outbreak began, reported on Tuesday

that a team of researchers led by Zhejiang University professor

Li Lanjuan have found that drugs Abidol and Darunavir can

inhibit the virus in vitro cell experiments.

Robin Shattock, head of mucosal infection and immunity at

Imperial College London, said he was now at the stage to start

testing the vaccine on animals as early as next week with human

studies in the summer if enough funding is secured, Sky news

said. The dollar also benefited from a rebound in risk appetite

with the greenback advancing 0.1% to 98.04, advancing for a

third consecutive day, and within striking distance of a

two-month high of 98.19 hit last week.

"FX markets are slightly optimistic as the infection rate

from the deadly China virus seems to have slowed somewhat but

still remains high at double digit rates," said Thu Lan Nguyen,

a FX strategist at Commerzbank based in Frankfurt.

Though the dollar has veered between acting as a classic

safe-haven asset during times of trade-war tensions and

benefitting from its status as a high-yielding currency in the

developed market space in 2019, the opening days of 2020 have

seen the greenback's correlation with risky assets strengthening

considerably.

As a result, the dollar weakened last week as news of the

spreading China virus hit risk sentiment globally, with only

stocks and risky assets gaining this week as China's response to

the coronavirus outbreak raised hopes it could be contained,

even as the death toll rose sharply.

With more than 99% of confirmed cases confined to China,

drastic quarantine measures in place and the central bank

pouring trillions of yuan into the financial system, investors

have partially unwound their recent flight to safety.

The Chinese currency in the offshore market rebounded

smartly 0.2% against the dollar CNH=D3 , rising past the 6.98

yuan per dollar line.

Australian dollar https://tmsnrt.rs/2trCVPs

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.